πŸ‡ΊπŸ‡Έ FDA
Patent

US 11072579

Treatment of cataplexy

granted A61KA61K31/27A61K31/325

Quick answer

US patent 11072579 (Treatment of cataplexy) held by Jazz Pharmaceuticals Ireland Limited expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/27, A61K31/325, A61K45/06, A61K9/0053